-transparent.png){kind=logo}
A small molecular weight biofunctional polymer, NED 137, has been investigated for its anti-neoplastic effect. Through its effect on the immune system, particularly the induction of B cell differentiation to antibody producing cells, this synthetic compound can retard tumour growth and prevent the development of distant metastases. Reactivity to tumour developed following administration of the NED 137. No toxicity has been observed. The polymer NED 137 is now being tested in phase I and phase II clinical trials.
Related Publications
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
July 1976,
Proceedings of the National Academy of Sciences of the United States of America,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
January 1986,
Cancer immunology, immunotherapy : CII,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
June 1954,
The Journal of hygiene,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
January 1991,
Cancer immunology, immunotherapy : CII,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
June 1951,
The Journal of genetic psychology,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
August 2013,
Current opinion in pharmacology,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
January 1970,
Humangenetik,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
January 1981,
Pharmacology & therapeutics,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
August 1991,
Immunology and cell biology,
R E Falk, and
L Makowka, and
N Nossal, and
J A Falk, and
J E Fields, and
S S Asculai
January 1986,
Complement (Basel, Switzerland),
